Northern Trust’s Lexaria Bioscience LEXX Stock Holding History

Northern Trust’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.3K	Buy	2,655 +1,429	+117%	+$15.5K	﹤0.01%	4363
2026 Q1	$14.3K	Hold	1,226	–	–	﹤0.01%	4356
2025 Q4	$11.3K	Hold	1,226	–	–	﹤0.01%	4429
2025 Q3	$17.5K	Hold	1,226	–	–	﹤0.01%	4385
2025 Q2	$16K	Hold	1,226	–	–	﹤0.01%	4355
2025 Q1	$31.4K	Hold	1,226	–	–	﹤0.01%	4292
2024 Q4	$38.6K	Hold	1,226	–	–	﹤0.01%	4297
2024 Q3	$56.1K	Hold	1,226	–	–	﹤0.01%	4184
2024 Q2	$51.1K	Hold	1,226	–	–	﹤0.01%	4208
2024 Q1	$66.8K	Buy	+1,226	New	+$46.9K	﹤0.01%	4176

Other funds holding LEXX

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Northern Trust's LEXX Position: Q2 2026 in Review

Northern Trust increased its Lexaria Bioscience (LEXX) stake by 117% in Q2 2026, buying an estimated $15.5K and bringing the position to 2,655 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Northern Trust first reported a position in LEXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $66.8K in Q1 2024. 29 funds tracked by Wall St. Rank hold LEXX as of Q2 2026.

Northern Trust held 2,655 shares of Lexaria Bioscience worth $22.3K as of Q2 2026.
Northern Trust bought 1,429 Lexaria Bioscience shares in Q2 2026, an estimated $15.5K.
Lexaria Bioscience made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4363 holding.
Northern Trust first reported a position in Lexaria Bioscience in Q1 2024 and has held it in 10 quarters since.
Northern Trust's Lexaria Bioscience position peaked at $66.8K in Q1 2024.
29 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.